-
Mashup Score: 0Globus Medical to acquire Nevro for $250M - 7 hour(s) ago
Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
Source: www.massdevice.comCategories: General Medicine News, General HCPsTweet
.@GlobusMedical to acquire @Nevro_HFX for $250M | #MnA #medicaldevices #SCS https://t.co/iTuBuWODdV